Disc Medicine Inc · News · TradingHolo

Disc Medicine Inc · News · TradingHolo

IRON news

Headlines tagged to this company

Disc Medicine's late-stage win clears path for approval of sun-allergy pill

Reuters · 2 d ago

Disc Medicine Stock Has Its Best Day Since 2022 as Drug Trial Revives FDA Approval Hopes — Barrons.com

Dow Jones Newswires · 2 d ago

Disc Medicine Shares Gain on Positive Trial Results for Erythropoietic Protoporphyria Treatment

Dow Jones Newswires · 2 d ago

Disc Medicine Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones Newswires · 2 d ago

Cantor Fitzgerald maintains Overweight rating on Disc Medicine, $170 price target

TradingView · 2 d ago

Disc Medicine's rare disease drug succeeds in late-stage trial

Reuters · 2 d ago

Disc Medicine Announces Success On All Primary And Secondary Endpoints In The Pivotal Phase 3 Apollo Trial Of Bitopertin In Adults And Adolescents With Erythropoietic Protoporphyria (Epp)

Reuters · 2 d ago

Disc Medicine posts late-stage trial win for lead asset developed with Roche

Seeking Alpha · 2 d ago

Disc Medicine: Phase 3 APOLLO shows significant PPIX reduction, +12.2 hrs pain-free light time

TradingView · 2 d ago

Disc Medicine Announces Success on All Primary and Secondary Endpoints in the Pivotal Phase 3 APOLLO Trial of Bitopertin in Adults and Adolescents with Erythropoietic Protoporphyria (EPP)

GlobeNewswire · 2 d ago

Disc Medicine rallies 32% as investors await bitopertin trial results

Seeking Alpha · 2 d ago

Disc Medicine to Host Corporate Webcast to Discuss Topline Results from the APOLLO Phase 3 Trial of Bitopertin in Erythropoietic Protoporphyria (EPP)

GlobeNewswire · 2 d ago

Disc Medicine Shares Polycythemia Vera Data, Outlines Late 2026 Trial Milestones

benzinga · 41 d ago

Disc Medicine Presents Initial Results from RESTORE-PV Phase 2 Trial in Patients with Polycythemia Vera (PV) at the 14th Society of Hematologic Oncology (SOHO) Annual Meeting

globenewswire · 41 d ago

Disc Medicine to Participate in Upcoming Investor Conferences

globenewswire · 49 d ago

Disc Medicine Announces Multiple Presentations Across Portfolio at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting

globenewswire · 50 d ago

Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewsWire · 63 d ago

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

PRNewsWire · 64 d ago

Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewsWire · 68 d ago

Bolt Metals to Rebrand as 26 Metals Inc. and Adopt the Ticker "IRON," Highlighting Its Focus on Flagship Florália Iron Project in Brazil's Iron Quadrangle

Accesswire · 69 d ago

← Previous More news →